COLLEGIUM PHARMACEUTICAL, INC
COLLOther · Large accelerated filer · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $177.8M | $144.9M | $566.8M | $463.9M | $276.9M | $310.0M |
| Operating income | $21.7M | $49.5M | $167.0M | $33.3M | $17.6M | $56.2M |
| Net income | $2.4M | $27.7M | $48.2M | −$25.0M | $71.5M | $26.8M |
| Total assets | $1.66B | $1.66B | $1.14B | $1.17B | $692.1M | $643.8M |
| Total liabilities | $1.36B | $1.43B | $947.9M | $979.3M | $489.1M | $457.8M |
| Equity | $301.7M | $228.8M | $195.4M | $194.8M | $202.9M | $186.0M |
| EPS (diluted) | $0.07 | $0.71 | $1.29 | $-0.74 | $1.86 | $0.76 |
| Shares out. | 31.5M | 32.0M | 34.1M | 33.4M | 34.8M | 34.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 12.2%
- Net margin
- 1.4%
- Return on equity
- 0.8%
- Return on assets
- 0.1%
- Return on capital (ROCE)
- 1.8%
- Liabilities / assets
- 81.8%
- Debt / equity
- 4.49×
- Book value / share
- $9.58
- Revenue growth (YoY)
- 22.7%
- Net income growth (YoY)
- −91.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 1.12grey zone
- Accruals / assets
- −19.7%clean
- Beneish M-Score
- -3.51normal
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 warning● 4 good- High leverage (liabilities > 70% of assets)
- Altman Z″ in the grey zone
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Eventide Asset Management, LlcPassive (13G)May 15, 2026
- Janus Henderson Group PlcPassive (13G)May 15, 2026
- Renaissance Technologies LlcPassive (13G)May 14, 2026
- Integrated Core Strategies (Us) LlcPassive (13G)May 12, 2026
- Invesco Ltd.Passive (13G)May 8, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Rubric Capital Management LpPassive (13G)Feb 13, 2026
- Principal Global InvestorsPassive (13G)Aug 11, 2025
- Pacer Advisors, Inc.Passive (13G)May 2, 2025
- Blackrock, Inc.Passive (13G)Apr 28, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Freund John GordonDirector | May 18, 2026 | Sell | 20 | $34.05 |
| Lurker NancyDirector | May 14, 2026 | Grant | 8,741 | $0.00 |
| Paya Carlos VDirector | May 14, 2026 | Grant | 8,741 | $0.00 |
| Freund John GordonDirector | May 14, 2026 | Grant | 8,741 | $0.00 |
| Glancy Donovan MichaelDirector | May 14, 2026 | Grant | 17,482 | $0.00 |
| Bohlin Garen GDirector | May 14, 2026 | Grant | 8,741 | $0.00 |
| Balice-Gordon Rita J.Director | May 14, 2026 | Grant | 8,741 | $0.00 |
| Santini GinoDirector | May 14, 2026 | Grant | 8,741 | $0.00 |
| Lurker NancyDirector | May 13, 2026 | Sell | 4,500 | $35.97 |
| Bohlin Garen GDirector | May 11, 2026 | Option exercise | 8,700 | $16.49 |
| Dieter DavidOfficer — EVP & General Counsel | Mar 17, 2026 | Tax withholding | 8,840 | $35.72 |
| Dieter DavidOfficer — EVP & General Counsel | Mar 18, 2026 | Sell | 13,976 | $34.92 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 6.0M | 11.2 | +0.5% |
| Apr 30, 2026 | 5.9M | 14.4 | -1.6% |
| Apr 15, 2026 | 6.0M | 10.7 | +9.1% |
| Mar 31, 2026 | 5.5M | 7.8 | +29.3% |
| Mar 13, 2026 | 4.3M | 7.4 | -7.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 15, 2026
- Completed an acquisition or disposition · Director / officer change · Regulation FD disclosureMay 12, 2026
- Results of operations · Regulation FD disclosureMay 7, 2026
- Director / officer changeApr 7, 2026
- Entered a material agreement · Regulation FD disclosureMar 19, 2026
- Results of operations · Regulation FD disclosureFeb 26, 2026
- Regulation FD disclosureJan 8, 2026
- Entered a material agreement · Terminated a material agreement · Unregistered equity sale · Regulation FD disclosureDec 30, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- S-8FORM S-8Jun 1, 2026
- S-8FORM S-8Jun 1, 2026
- 4May 20, 2026
- 4May 18, 2026
- 4May 18, 2026
- 4May 18, 2026
- 4May 18, 2026
- 4May 18, 2026
- 4May 18, 2026
- 4May 18, 2026
- 144May 18, 2026
- 3May 18, 2026
- 8-KFORM 8-KMay 15, 2026
- 4May 15, 2026
- SCHEDULE 13GMay 15, 2026
Event-driven situations (5)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.